CEACAM6 silencing suppresses tumour growth and sensitises cholangiocarcinoma to cisplatin

Abstract Background The CEACAM family, a major subgroup of the carcinoembryonic antigen (CEA) family, is widely expressed in normal and neoplastic tissues. Although CEACAM6 overexpression has been reported in cholangiocarcinoma (CCA), the molecular mechanisms by which it modulates chemosensitivity i...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Shi‐Jia Dai, Jiang‐Qi Tan, Jia‐Qi Guo, Ya‐Nan Zhou, Teng Huang, Hao‐Lin Jiang, Yang Liu, Li‐Wei Dong, Zhen‐Gang Yuan
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2026-02-01
Serija:	Clinical and Translational Discovery
Teme:	CEACAM6 cholangiocarcinoma cisplatin DNA damage ribosome biogenesis
Online dostop:	https://doi.org/10.1002/ctd2.70126
Oznake:	Označite Brez oznak, prvi označite!